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Time-dependent aspects of osmolyte changes in rat kidney, urine, blood
and lens with sorbinil and galactose feeding. Sorbitol plus myo-inositol,
betame and glycerophosphorylcholine (GPC) are cellular osmolytes in the
mammalian renal medulla. Galactosemia and hyperglycemia can cause
excessive levels of galactitol or sorbitol in several organs via aldose
reductase (AR) catalysis. AIR inhibitors can reduce these polyols. To
examine osmolyte responses to polyol perturbations, male Wistar rats
were fed normal diet, the AR inhibitor sorbinil (at 40 mg/kg/d), 25%
galactose, or a combination, for 10, 21 and 42 days. All animals at 21 days
had higher apparent renal AR activity than at 10 or 42 days, possibly
providing resistance to sorbinil. Sorbinil feeding alone tended to increase
urinary, plasma and renal urea levels. It reduced AR activity and sorbitol
contents in renal inner medulla, though less so at 21 days; other renal
osmolytes, especially betaine, were elevated. Galactose feeding caused
little change in renal AR activity, and resulted in high galactose and
galactitol contents in renal medulla, urine, blood and lens (and higher
renal Na contents at 10 days). Renal sorbitol, inositol and GPC
decreased, while betaine contents trended higher at all times. Sorbinil-
galactose feeding reduced renal AR activities and galactitol contents
(again less so at 21 days), urine, blood and lens galactitol, and further
reduced renal sorbitol contents. At 10 and 21 days it tended to raise renal
betaine more, and restore inositol (but not GPC) contents to control
levels. At 42 days it reduced renal and urinary Na and galactose, and
decreased renal betaine to control levels. Under most conditions, total
renal (non-urea) organic osmolyte contents (presumed to be mostly
intracellular) and Na plus galactose contents (presumed mostly extracel-
lular) changed together such that cell volumes may have been maintained.
The exception was 10 days on galactose, where total osmolytes appeared
too low. In galactose-fed animals, urine/plasma ratios suggest some renal
galactitol efflux, and cellular galactitol probably helps maintain osmotic
balance rather than cause swelling.
Mammalian renal medulla cells must cope with high external
salt concentrations produced by the kidney's urine-concentrating
mechanism. Like cells of a wide variety of organisms exposed to
hypertonicity, renal cells apparently maintain cell volume with
"compatible" organic osmolytes, solutes which do not exhibit the
disruptive effects on macromolecules that occur with high NaC1 or
KC1 [1, 2]. Compatible osmolytes in most organisms are polyols,
methylamines, and free amino acids [2]; in the mammalian renal
medulla, the major ones are sorbitol, myo-inositol, glycerophos-
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phorylcholine (GPC), and betaine (N-trimethylglycine) [3]. Initial
studies, which altered renal osmotic conditions through variations
in water or salt intake, showed that total renal contents of
osmolytes are up- and downregulated [3—7], tracking sodium
contents in antidiuretic and diuretic states such that cell volume is
probably maintained [1, 5, 7].
Recent studies have focused on regulation of individual os-
molytes. Polyols are of particular interest because of unusual
conditions which perturb them. First, excesses occur in diabetic
hyperglycemia and galactosemia, in which glucose or galactose is
converted to largely unmetabolized sorbitol or galactitol [8, 9],
respectively, in tissues with aldose reductase (AR; EC 1.1.121),
including lens, renal cortex and medulla, and neurons. It is
thought that damaging osmotic pressures may result. Also, there
is often a depletion of cell myo-inositol contents [8—10].
Second, decreases in polyols result from AR inhibitors, drugs
which have been developed to reduce sorbitol or galactitol
accumulation. These have been shown to be beneficial in hyper-
glycemia and galactosemia to some tissues including the kidney,
though not consistently [8—14]. However, since sorbitol is used in
normal renal osmoregulation, we have suggested that AR inhib-
itors could impair this function and perhaps cause osmotic
shrinkage [151.
Thus it has been hypothesized that polyol changes up or down
may be osmotically damaging. However, previous renal studies of
this have not been consistent. In vitro, we used PAP cells, a
cultured renal line which relies heavily on sorbitol as an osmolyte.
These cells in high glucose media had elevated sorbitol contents
concomitant with reduced growth, consistent with high sorbitol
causing cell swelling. AR inhibitors reduced the sorbitol build-up,
which restored growth at low doses, but caused large decreases in
both sorbitol and viability at high doses [15]. In vivo studies
showed somewhat different patterns. In female Sprague-Dawley
rats fed 50% galactose for 10 days, Bondy et al [161 reported that,
along with high renal galactitol contents, there were large reduc-
tions in AR mRNA, sorbitol, inositol and GPC contents. The
authors proposed that these were adaptive events (such as feed-
back inhibition) to maintain cell volume in the presence of excess
polyols, perhaps by avoiding the damage seen in PAP cells. The
changes caused by galactosemia were mostly reversed by the AR
inhibitor, sorbinil. As with PAP cells, however, osmotic stress was
suggested because total osmolytes appeared lower than needed
for volume maintenance [16].
In studying AR inhibition alone in vitro, we found in PAP cells
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that AR inhibitors reduced sorbitol contents and, consistent with
cell shrinkage, greatly impaired survival of these cells in high-salt
(but not normal) media [15]. However, others found that betaine
added to culture media provided a substitute osmolyte which
restored growth [17]. In vivo, we fed normal male Wistar rats
sorbinil for 10, 21 and 71 days. In the 10- and 71-day treatments,
sorbitol contents of inner medullas fell greatly, but in apparent
compensation, betaine contents increased such that cell volume
was likely maintained [18, 19]. Therefore betaine and sorbitol may
serve as interchangeable compatible osmolytes in vitro and in vivo,
eliminating osmotic problems.
However, a different pattern was seen in our 21-day treatment:
neither sorbitol nor betaine levels were significantly altered,
suggesting another type of compensation, such as up-regulation of
sorbitol production (not tested for in that study) [18]. Yet a third
pattern was reported by Bondy et al [16] for rats fed sorbinil for
10 days: sorbitol contents decreased but no other cellular os-
molytes increased enough to compensate, suggesting osmotic
stress under AR inhibition.
Thus several different, sometimes conflicting patterns in renal
osmolytes and possible cell stress have been reported under
different times and types of polyol perturbations. To further
elucidate responses of renal osmolytes to such perturbations, we
treated Wistar rats with dietary sorbinil and/or galactose for 10, 21
and 42 days, and measured renal AR activities and, for the first
time together, osmolytes in several tissues. We hypothesized that
polyol disturbances could cause osmotic problems (from excesses
or deficits) or trigger compensatory changes in other renal
osmolytes, with the type and degree of response possibly being
age- or time-dependent.
Methods
Animals and surgical procedures
All animals were male Wistar Rats initially 41 to 44 days old
(COBS, Charles River, Wilmington, MA, USA), housed under
standard conditions and given Purina Rodent Chow (5001, Purina
Mills, St. Louis, MO, USA) and water ad libitum for 7 to 10 days
before the experiments were started. In each of three experiments
conducted for 10, 21 and 42 days, four groups of animals were fed
ground chow, with the first group as control (Control 10 days, 21
days, 42 days), the second (Sorbinil 10 days, 21 days, 42 days) fed
ground chow with sorbinil at 40 mg/kg/day, and the third (Galac-
tose 10 days, 21 days, 42 days) and fourth (Sorbinil + Galactose 10
days, 21 days, 42 days) groups treated as the first and second,
respectively, but with 25% galactose added in their chow. All
animals were given water ad libitum throughout. Water and food
consumption and body wt were determined eveiy one to three
days; urines were collected for two 24-hour periods near the end
of the 10 and 42 day experiments. Animals were anesthetized with
CO2 and killed by cervical dislocation. Urine samples, when
present, were taken from the bladder with a syringe; blood
samples were collected from the renal artely for 10- and 42-day
animals. Both were centrifuged for 10 minutes at 12,000 rpm
(microcentrifuge). Lenses from 10- and 42-day animals and one
kidney from each animal were frozen in liquid nitrogen in vials
and stored at —70°C for later analysis.
Aldose reductase measurements
The second kidney was immediately dissected on a petri plate
on ice to obtain the inner medulla. The medulla was weighed to
the nearest 0.1 mg, then homogenized in a glass homogenizer in
19 vol cold buffer [10 mivi N-2-hydroxyethylpiperazine-N'-2-eth-
anesulfonic acid (HEPES), 5 mri EDTA, 2 m ethylene glycol-
bis(b-aminoethyl ether)-N,N,N',N'-tetraacetic acid [EGTAJ, 2
mM dithiothreitol, pH 7.0). The homogenates were centrifuged in
a microcentrifuge for 15 minutes at 10,000 rpm. Supernatants
were analyzed kinetically at 37°C for aldose reductase activity with
10 mM glyceraldehyde or xylose as substrates in 100 mM Na-PO4
buffer (pH 7.0) with 100 mM NADPH [201.
Protein and osmolyte analyses
Frozen kidneys were thawed in a cold room, and inner medullas
were immediately removed and weighed to the nearest 0.1 mg,
followed by homogenization in a glass homogenizer in 9 vol cold
7% perchloric acid. Lenses were treated similarly. The homoge-
nates were centrifuged for 15 minutes at 10,000 rpm (microcen-
trifuge); 50 1d aliquots were removed from each homogenate for
Na analysis (see below). The pellets were dissolved in 1 ml of 1
N NaOH, then analyzed for protein with the Bio-Rad assay
(Bio-Rad Laboratories, Richmond, CA, USA), using y-globulin
treated similarly (perchioric acid, NaOH) as a standard. The
remaining supernatant was neutralized to pH 6.8 to 7.5 with 1 M
KOH. The samples were passed through Bond Elut C18 cartridges
(Varian, Harbor City, CA, USA) and 0.45-mm HV filters (Milli-
pore, Bedford, MA, USA). Overall tissue dilution was 20-fold.
Peaks were identified using standards treated similarly.
Urine and plasma samples were analyzed for osmotic pressure
using a vapor pressure osmometer (Wescor, Logan, UT, USA),
then treated in the same manner as medullas, starting with
perchloric acid treatment (2:1 vol added to plasma). In the 42 day
experiment, whole blood was also treated. Overall urine dilution
was 15-fold, plasma and blood dilution fivefold.
Sodium in all samples was analyzed by flame photometry
(Cole-Parmer, Chicago, IL, USA). Organic osmolytes were ana-
lyzed using high-performance liquid chromatography (HPLC) as
previously described [21] with a Sugarpak-I column (Waters,
Milford, MA, USA) with peak detection by refractive index. The
column separated tissue galactose, myo-inositol, GPC, galactitol,
sorbitol, urea, and betaine at 70°C, with a detection limit of about
4 /LM for 50 il injections.
Because of unknown peaks interfering with myo-inositol and
galactose HPLC peaks in urine (but not tissue) samples, inositol
was analyzed enzymatically as previously described [22], and the
carbohydrates were also analyzed by GC-MS (5890/5971A,
Hewlett-Packard, Palo Alto, CA, USA). Thirty-five microliters
standards or samples, with 14 jtl of 2.5 m'vi mannitol added as
internal standard, were dried in 0.1 ml reaction vials in a vacuum
over NaOH pellets. To the vials 15 jil acetonitrile and 20 l
bis-trimethylsilyl-trifluoroacetamide were added; vials were capped
with Teflon inserts and heated at 90°C for two hours [4]. One
microliter samples were injected (split injection) onto a 30 m X
0.33 mm non-polar HP-i column (Hewlett-Packard), run at 50°C
for two minutes, ramped at 10°C/mm to 170°C, held there for 17
minutes, then ramped at 5°C/mm to 180°C. This separated
trimethylsilated galactose, mannitol, sorbitol, galactitol and myo-
inositol. Resolution was limited to 30 I.LM. Peaks were identified
by spectrum library and standards treated similarly.
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Table 1. Concentrations of major osmolytes in urines, and protein contents of renal inner medullas, of rats treated in four dietary groups for times
indicated
Urine solute concentrations (mM SD) Renal inner medulla
% proteinGroup N Sodium Urea Galactose Galactitol
A. 10 days
Control 10 days 3 165 31 326 102 ND ND 6.11 0.99
Sorbinil 10 days 4 203 45 479 82 ND ND
Galactose 10 days 5 178 57 285 48" 403 86 24.7 9,4a
Sorbinil + galactose 10 days 4 187 56 261 27" 290 121 3.1 0.5
6,38 0.38
7.82 0.68a
6.51 1.10
B. 21 days
Control 21 days 3 114 35 444 95 ND ND 6.55 0.52
Sorbinil 21 days 3 111 52 526 70 ND ND 6.31 0.89
Galactose 21 days 3 103 36 271 89 320 237 31.3 17.2a 6.60 1.10
Sorbinil + galactose 21 days 5 72 31 217 108k 396 99 4.4 0.6 6.20 0.51
C. 42 days
Control 42 days 3 169 24 462 111 ND ND 7.42 0.97
Sorbinil 42 days 5 193 40 711 178k ND ND
Galactose 42 days 6 114 57" 359 83b 392 178 31.9 7.5
Sorbinil + galactose 42 days 6 91.7 29.5a 379 152" 248 177k 6.5 3.0
7.02 0.53
7.41 0.97
7.28 0.58
N indicates number of animals; ND, not detected.
a Significantly different from Control group (P < 0.01, SNK multiple comparison tests)b Combined galactose treatments had a significant effect (P < 0.005) by 2-way ANOVA
"Significantly different from Galactose group (P < 0.01, SNK multiple comparison tests)
Table 2. Concentrations of major osmolytes in plasmas of rats treated in four dietary groups for 42 days
Plasma solute concentrations (mM su), 42 days
Group N Sodium Urea Galactose Galactitol
Control 42 days 4 143 4 7.90 0.57 ND ND
Sorbinil 42 days 4 147 2 9.31 1.03 ND ND
Galactose 42 days 4 148 7 7.22 0.79 5.99 1.70
Sorbinil + galactose 42 days 4 144 6 7.22 0.61 3.94 1.80a
0.254 QQ47a
0.028 0,016ab
Blood/plasma ratio" 0.62 0.05 0.96 0.13 0.69 0.13 1.50 0.26
N indicates number of animals; ND, not detected.
a Significantly different from Control group (P < 0.05, SNK multiple comparison tests)
"Significantly different from Galactose group (P < 0.001, SNK multiple comparison tests)
C Calculated for individual animals for all groups combined (for sodium, urea) or Galactose and Sorbinil + galactose groups combined (for galactose,
galactitol)
Statistical methods
Statistics were performed by two-way analysis of variance,
followed by Student-Newmann-Keuls (SNK) multiple comparison
tests, and by Student's two-tailed t-tests, using Statworks (Cricket,
Philadelphia, PA, USA) and Instat 2.0 (GraphPad, San Diego,
CA, USA). Sorbinil was provided by Pfizer Central Research
(Groton, CT, USA). Other chemicals were purchased from Sigma
Chemical (St. Louis, MO, USA) and Boehringer-Mannheim
(Indianapolis, IN, USA).
Results
Live animal, urine, blood and lens measurements
Body weight gain was not affected by any experimental condi-
tion (data not shown). Galactose-fed (Galactose and Sorbinil +
Galactose) animals ate significantly more food (20%), drank more
water (average 83 mi/day compared to 47 for the Control plus
Sorbinil groups), had greater urine output (measured in 10 and 42
day groups: 40 to 49 ml/day compared to 13 to 19 mllday for
Control plus Sorbinil groups), and tended to have larger kidneys
(P < 0.05 at 42 days; average 2.2 g compared to 1.8 g for Control
plus Sorbinil groups). Urine osmolalities were highly variable
(from 800 to 1600 mOsm/kg) and did not differ among groups.
Urines of Sorbinil animals tended to have elevated urea levels
which were significant at 10 and 42 days (Table 1A, C). Those of
Galactose animals had high galactose and galactitol concentra-
tions and lower urea concentrations (Table 1), and lower Na
concentrations in the 42 day group (Table 1C). Sorbinil +
Galactose urines showed similar patterns but had greatly reduced
levels of galactitol in all cases (Table 1). No methylamines were
found in urines; traces (<1 mM) of inositol and sorbitol were
found in a few scattered urine samples, but with no significant
trends.
In plasmas, analyzed at 10 days (data not shown) and 42 days
(Table 2), glucose (not shown), Na and urea concentrations did
not differ, except for elevated urea in the 42 day Sorbinil group
(Table 2). Plasmas of galactose-fed groups at 10 days (not shown)
and 42 days (Table 2) had high galactose and some galactitol
accumulation, but with galactitol reduced tenfold in the Sorbinil
+ Galactose group. For 42-day animals, whole blood was also
analyzed. Rupturing blood cells had little effect on urea concen-
trations relative to plasma; however, it reduced concentrations of
Na and galactose by 30 to 40%, indicating their primarily
extracellular location, and it elevated galactitol concentration by
50%, indicating its primarily intracellular location (blood/plasma
ratio, Table 2).
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Table 3. Contents of major osmolytes in lenses of rats, treated in four dietary groups for 10 and 42 days
Group N
Lens solute contents, 10 days Lens solute contents, 42 days
Galactose GalactitolGalactose Galactitol
Galactose 5 2.20 l.32a 187 11.6 0.35 0.29a 53.7 11.7a
Sorbinil + galactose 5 2.47 0.93a 24.5 128ab 0.39 0.26a 31.5 6.8w'
N indicates number of animals. Galactose contents are in mmol/kg wet wt (± so), galactitol in mmol/kg protein (± so; protein content of lenses
averaged 32 5%). Control and Sorbinil groups (not shown) had no detectable levels of these solutes.
a Significantly different from Control group (P < 0.05, SNK multiple comparison tests)b Significantly different from Galactose group (P < 0.05, SNK multiple comparison tests)
Average urine/plasma ratios (U/P) for galactose (in all galac-
tose-fed groups) and urea (in all groups), compounds mainly
concentrated from blood, were statistically identical in 10 and 42
day groups, ranging from 58 to 65. For galactitol the U/Pratios
ranged were 104 and 125, respectively, for the 10 and 42 day
Galactose groups, suggesting some urinary galactitol arose from
the kidney itself (the ratios were around 200 for the Sorbinil +
Galactose animals, but as plasma levels were near the HPLC
detection limit, these ratios cannot be regarded as accurate).
Lenses were examined for at 10 days and 42 days. In galactose-fed
groups, galactose and galactitol accumulated, but to considerably
lower levels in the 42-day group (Table 3). Sorbinil treatment
reduced the galactitol contents in both, but resulted in much less
relative decrease in the 42 day case (Table 3). Lens protein
contents (averaging 32 5%) did not differ among the groups.
Renal protein contents and aldose reductase activities
In previous studies we reported osmolyte contents as mmol/kg
wet wt [18, 22]. In those studies, tissue protein contents (% ofwet
wt) did not differ among groups. We now report contents as
mmol/kg protein, because of an increase in kidneys of the
Galactose group at 10 days (Table 1A). Protein contents did not
differ among groups at 21 and 42 days (Table 1B,C).
As measured with glyceraldehyde as substrate (G bars in Fig. 1),
animals in the 21 day experiment had more apparent renal aldose
reductase (AR) activity than older and younger animals in all four
dietary tests (P < 0.001 for most comparisons; Fig. 1). Sorbinil
feeding greatly reduced AR activity per kg protein in medullary
extracts in both treatment types at all times. Galactose feeding
had little effect on AR activity except for a small decrease in
10-day animals (Fig. 1).
AR rates were measured in a 400-fold tissue dilution (in the
assay cuvette), and probably reflect inhibition by sorbinil in the
extract rather than down-regulation of the enzyme in the cells.
The inhibition constant for sorbinil is 0.01 M [23]; assuming that
the consumed sorbinil (40 mg/kg/day) was evenly distributed in
the animal, the extract in the cuvette would have had at least 1 p.M.
Assays for AR activity were also run with xylose as substrate in
order to distinguish between aldose and other reductases. For
example, activity of rat kidney aldehyde reductase with 10 mM
xylose is reportedly 0.7% of the activity with 10 mtvi glyceralde-
hyde [24], while that of AR from cultured rabbit kidney (PAP)
cells is 46% [23]. Xylose-based measurements showed the same
patterns as with glyceraldehyde, except that activity was not higher
in the 21-day-old groups compared to older and younger groups,
as it usually was with glyceraldehyde (X vs. G bars in Fig. 1).
Velocities with xylose were 46 to 60% of the glyceraldehyde
activity in the 10 and 42 day experiments (no significant difference
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Fig. 1. Aldose reductase activities (units/kg protein) measured in crude renal
medulla,y extracts with 10 m glyceraldehyde (G bars) or xylose (X bars) as
substrate. Symbols are: (1J) control; (i) sorbinil; () galactose; ()
galactose + sorbinil. 4P < 0.05 compared to Controls, fP < 0.05
compared to Galactose groups, by ANOVA followed by SNK multiple
comparison tests; §P < 0.05 compared to same test at other time points;
error bars indicate so.
among groups), suggesting that mainly aldose reductase was being
measured. But they were 31 to 35% of the glyceraldehyde activity
in all 21 day groups (Fig. 1), suggesting the presence of other
reductases (Discussion).
Renal osmolytes: Sorbinil or galactose treatment
Renal osmolyte patterns were similar, with a few differences, at
the three time periods of sorbinil treatment (data in Sorbinil rows,
Tables 4 to 6, plotted as percentages of Control values in Fig. 2A).
Contents of Na and urea did not change in any case. Renal
sorbitol contents were greatly reduced in all cases, although in the
21 day case the amount of reduction was less (Fig. 2A). In
apparent compensation, betaine contents in all cases trended
upwards (Fig. 2A), and were significant at 10 (Table 4) and 42
days (Table 6). Inositol and GPC also increased significantly at 42
days.
Galactose feeding alone produced similar patterns in most
renal osmolytes in all three time periods (Galactose rows in
Tables 4 to 6, plotted as percentages of Control values in Fig. 2B).
Na and urea contents did not change in any case except for
increased Na at 10 days (Table 4). High levels of galactose
(Tables 4 to 6) and galactitol (Gl bars in Fig. 2B) were found in all,
increasing the total AR-catalyzed polyoi content (GI + S bars,
10 days 21 days 42 days
Time of treatment
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Fig. 2. Contents of major osmolytes in renal inner medullas of sorbinil-
treated (A), galactose-fed (B) and sorbinil plus galactose-fed (C) rats, using
data from Tables 4 to 6 converted to percentages of appropriate Control
groups (horizontal line at 100%), with galactitol (Gi bars) plus sorbitol (S
bars) values compared to Control sorbitol levels. Symbols are: (D) sorbitol +
galactitol; () inositol; () betaine; () GPC. *P < 0.05 compared to
Controls, tP < 0.05 compared to Galactose groups, by ANOVA followed
by SNK multiple comparison tests or (*) by t-test; error bars indicate SD.
Fig. 2B). In the 21 day case, galactitol accumulation was signifi-
cantly higher than at 10 or 42 days (Tables 4 to 6). There were
trends towards decreased inositol and GPC, significant at 10 and
21 days, and decreased sorbitol contents in all (Fig. 2B). In
contrast, betaine contents tended to increase, significantly so at 21
and 42 days (Fig. 2B).
Renal osmolytes: Sorbinil plus galactose treatment
Sorbinil plus galactose feeding resulted in somewhat different
patterns at the three time periods (Sorbinil + Galactose rows in
Tables 4 to 6, plotted as percentages of Control values in Fig. 2C).
Na and urea contents did not change, except for decreased Na
at 42 days (Table 6). In all cases, galactitol levels were significantly
1 reduced compared to the Galactose group; sorbitol levels were
reduced compared to all other groups. Galactose contents also fell
at 42 days (Table 6). GPC contents (Fig. 2C) remained similar to
their depressed states seen in untreated galactosemia (Fig. 2B).
At 10 and 42 days, total galactitol plus sorbitol was reduced to
about the level of sorbitol in Control animals, but at 21 days this
total was higher (Gl + S bars, Fig. 2C). Other patterns were
similar at 10 and 21 days: inositol contents were restored to
control levels; betaine contents increased above control levels,
tending higher than in Sorbinil or Galactose groups (Tables 4 to
5; Fig. 2C). At 42 days, the depletion in renal Na content was
concurrent with betaine reduced significantly relative to the
__________
_____ _________ Galactose groups (Fig. 2B), back to control levels (Fig. 2C).
Renal cell-volume maintenance
To test whether poiyol perturbations lead to cell volume
imbalances, we made the following assumptions about renal cells.
First, urea is thought to equilibrate across cell membranes, while
Na may be largely extracellular and the normal polyols and
methylamines are likely intracellular [3, 25]. Second, the galactose
225 in renal extracts should be mainly extracellular, given the blood-
200 plasma ratios (see above; Table 2) and the high levels in urine(Table 1) compared to renal tissue (Tables 4 to 6). Third, we
175 initially assumed that most of the galactitol is in cells, where it is
' 150 synthesized (see Discussion). Thus an estimate of cell volume
control may be obtained by comparing contents of Na + galactose
125 to total methylamines + polyols including galactitol ("total or-
100 ganic osmolytes"). These are plotted as percentages of Controls ing Figure 3. Relative osmotic effects of Na + galactose in this figure
a) 75 are underestimated, since cellular osmolytes presumably respond
50 to increase in extracellular osmotic pressures above isosmotic
E levels, not above zero. Nevertheless, Figure 3 suggests general(I) ,o ' trends.
0 Despite reduced renal sorbitol contents in all Sorbinil animals,
the same total organic osmolytes (Fig. 3, left) were seen at 10 and
21 days, due to increased betaine (though not significant at 21
days) (Fig. 2A). The simultaneous increase in GPC and inositol at
A
10 days 21 days 42 days
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Table 4. Contents of major osmolytes in renal inner medullas of rats, treated in four groups for 10 days
Group N
Renal medullary osmolyte content
mmollkg wet wt SD mmollkg protein SD
Sodium Galactose Urea Galactitol Sorbitol Inositol Betaine GPC
Control 10 days
Sorbinil 10 days
5
5
199 8
204 14
ND
ND
149 63
164 58
ND
ND
58.3 12.3
16.1 3.8a
303 18
312 38
117 34
166 27"
275 42
263 13
Galactose 10 days 6 234 15 27.4 16.4' 197 44 201 29' 28.5 6.7a 207 43' 161 37 179 22'
Sorbinil + galactose 10 days 6 196 14' 19.3 13.2' 172 21 64.9 18.8" 5.2 4.1" 278 22C 217 40'' 202 26'
Significance (p)d
Sorbinil 0.004 NS NS <0.001 <0.001 <0.001 0.003 NS
Galactose 0.035 <0.001 NS <0.001 <0.001 0.006 0.005 <0.001
Interaction 0.002 NS NS <0.001 0.008 0.039 NS NS
N indicates number of animals; ND, not detected.
a Significantly different from Control group (P < 0.05, SNK multiple comparison tests; or b by two-tailed Student's t-test)
'Significantly different from Galactose group (P < 0.05, SNK multiple comparison tests)
d Two-way analysis of variance; NS = not significant (P> 0.05)
Fig. 3. Contents of Na (Na bars) plus
Galactose (Ga bars) and the total of GPC,
betaine, sorbito4 inositol, and galactitol (GI bars)
("total oanic osmolytes") in renal inner
medullas of non-control rats of Tables 4 to 6. The
shaded bars indicate total organic osmolytes.
Totals were calculated by summing osmolytes
for each individual animal before statistical
analysis, then converted to percentages of
appropriate control group (horizontal line at
100%). 'P < 0.05 compared to Controls,
tP < 0.05 compared to Galactose groups, by
ANOVA followed by SNK multiple comparison
tests; error bars indicate SD.
42 days (Fig. 2A) yielded a higher average total, but not signifi-
cantly compared to controls (Fig. 3). Galactose animals probably
had increased extracellular renal osmotic pressures due to galac-
tose. At 10 days this correlated with higher renal Na (and
protein) contents, but the higher external solute level (Na +
galactose) was not matched by an increase in total organic
osmolytes (Fig. 3, middle 10 days), where high galactitol and
betaine contents were offset by decreased sorbitol, GPC and
inositol (Fig. 2B). At 21 and 42 days, however, organic osmolyte
contents apparently matched external solutes (Fig. 3 middle). In
Sorbinil + Galactose animals, total organic osmolytes appeared to
match Na + galactose contents at 10 and 42 days even though Na
and galactose were reduced in the latter (Fig. 3, right). At 21 days,
the variability in galactose was too great to estimate osmotic
balance.
Discussion
Previously it has been proposed that polyol perturbations could
cause osmotic problems in tissues with aldose reductase (AR).
However, while some work has suggested this may happen in renal
systems, other has shown that compensating processes may occur
(see Introduction). Our results indicate that the kidney generally
does compensate for polyol disturbances; in particular, betaine
appears to be used consistently to replace osmolytes which have
been reduced, confirming findings of other studies [16—191. How-
ever, using renal, blood and urinary analyses done together for the
first time, we suggest in contrast to others (such as [161) that
galactitol might not cause cell swelling, and that not all osmolyte
responses are directly adaptive for cell volume regulation. Finally,
we propose that the apparent inconsistencies among previous
studies may be due to age of animals used—because of develop-
mental changes in AR—or to length of treatment.
Responses to high galactose and galactitol
Galactose feeding, as expected, caused a large increase in
galactitol in the renal medulla (Fig. 2B). Potentially this could
cause osmotic swelling, thought to be a source of damage from
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Table 5. Contents of major osmolytes in renal inner medullas of rats, treated in four groups for 21 days
Group N
Renal medullaiy osinolyte content
mmol/kg wet wt so mmollkg protein SD
Sodium Galactose Urea Galactitol Sorbitol Inositol Betaine GPC
Control 21 days
Sorbinil 21 days
Galactose 21 days
Sorbinil + galactose 21 days
5
5
4
6
174 17
184 15
199 8
187 21
ND
ND
28.3 8.9a
30.3 15.5°
168 72
194 14
144 61
140 15
ND
ND
308 53°
76.2 11•6ab
49.5 15.4
29.8 6.0°
21.6 8.2°
7•3 1,2ab
194 29
199 25
133 16°
188 25b
96.6 27.9
117 22
137 27°
162 21°
228 15
243 28
165 27°
184 37°
Significance (P)°
Sorbinil
Galactose
NS
NS
NS
<0.001
NS
0.07
0.001
<0.001
<0.001
<0.001
0.03
<0.008
0.05
<0.001
NS
<0.001
Interaction NS NS NS 0.001 NS 0.04 NS NS
N indicates number of animals; ND, not detected.
aSignificantly different from Control group (P < 0.05, SNK multiple comparison tests)bSignificantly different from Galactose group (P < 0.05, SNK multiple comparison tests)
Two-way analysis of variance; NS, not significant (P> 0.05)
polyol accumulation in diabetic hyperglycemia [8] and galac-
tosemia [9]. However, our results argue against such damage in
the inner kidney, as there are three possible effects that may
prevent it:
(1.) Our urine and blood data suggest that galactose is elevated
extracellularly in the medulla, such that increases in cellular
osmolytes might be necessary to balance this. Galactitol in renal
cells might thus become a useful osmolyte (Fig. 3 middle, 21 and
42 days).
(2.) Galactitol effiux, suggested by the presence of this polyol in
urine (Table 1), may reduce cell volume changes if there is excess
galactitol. Urinary galactitol could be concentrated from blood
(from other organs), but since our U/P ratios for galactitol were
twice those for urea or galactose, at least some is probably is from
the kidney itself. Efflux could be due to membrane damage from
cell swelling, or through a polyol release channel. The former is
unlikely given that other osmolytes were not detected in urines.
The detection limit of HPLC was 60 LM for undiluted samples;
with levels of some osmolytes as high as galactitol in the kidney
(Tables 4 to 6), some should have been detectable in urines (Table
1) had there been nonspecific membrane leakage. A specific
apical membrane sorbitol permease has been reported in cultured
renal (PAP) cells, which allows for fast release of sorbitol during
diuresis [26], though work on primary cultures of inner medulla
cells suggests a basolateral sorbitol channel [27].
If some renal galactitol is extracellular, it would alter the
solute-total bars in Figure 3 somewhat. This would make the
apparent imbalance at 10 days on galactose (Fig. 3 middle) even
worse, but conclusions about other galactose and the sorbinil-
galactose groups probably would not change.
(3.) Finally, in the presence of high galactitol, other renal
osmolytes (sorbitol, inositol and GPC) generally decreased (Fig.
2B). Bondy et al [16], who found the same pattern in galactose-fed
Sprague-Dawley rats, suggested these changes were specific ad-
aptations to reduce excess osmotic pressure. However, we suggest
that they are not necessarily mechanisms for cell volume regula-
tion, but could be side effects of galactosemia, for the following
reasons.
First, for sorbitol, Bondy et a! [16] concluded that galactitol
accumulation exerts feedback inhibition on AR gene transcrip-
tion, since they found 60% reduction in papillary AR mRNA after
10 days of galactosemia, an effect largely reversed by sorbinil
treatment (they did not measure AR activity). However, in our
study, while there was a small (26%) reduction in AR activity in
medullary extracts at 10 days of galactose feeding, there were no
reductions at later times (Fig. 1). These results are not necessarily
contradictory. Wu et a! [28] recently reported that in rats on 21
days of galactose feeding, there was little correlation in kidney and
other organs between AR activity and mRNA, with the former
often showing little change despite large changes in the latter.
They suggested that translation, activation and/or turnover may be
more important than mRNA levels in determining tissue AR
activities [28J. We suggest that sorbitol reduction in our Galactose
animals is due more to AR-substrate competition than to feed-
back inhibition, especially since AR has a higher affinity for
galactose than for glucose [9].
Second, while renal GPC levels fell in Galactose animals, they
remained depressed in Sorbinil + Galactose groups (Fig. 2B, C).
Therefore, GPC does not appear to be regulated in response to
polyol changes directly. Instead, GPC contents may be altered to
track urea contents, which tended to decrease in all galactoseafed
groups. This is not suprising given the diuresis galactose feeding
induced (increased animal drinking and urinary output) in this
and other studies [9, 10]. GPC has been hypothesized to act as a
macromolecule-stabilizing osmolyte to counteract the perturbing
effects of urea [1, 29]. Several studies have shown that renal GPC
contents co-vary with urea levels in kidney and urine [1, 5, 22, 29,
30]. A similar correlation (P = 0.02) was found in our data
between urinary urea and renal GPC. For example, renal, plasma
and urinary urea levels were highest in 42-day Sorbinil kidneys,
lowest in 21-day Sorbinil + Galactose kidneys (Tables 1, 2, 5, 6);
these groups had the highest and near-lowest levels of renal GPC
(Tables 5, 6).
Third, inositol downregulation appears linked to AR-polyol
accumulation, since sorbinil-galactose feeding both reduced ga-
lactitol content and restored inositol contents to control levels
(Fig. 2C). Inositol depletion has been seen in many tissues that
accumulate sorbitol in hyperglycemia, or galactitol in galac-
tosemia, though depletion is not consistent [31]; e.g., inositol (and
sorbitol) contents increased in one study in outer medullas of
streptozotocin-diabetic rat kidneys [11]. Most workers have pro-
posed depletion to be a nonadaptive side effect, harmful to cell
functions [31, 32]. Nevertheless, in organs such as kidney it could
be adaptive if inositol is reduced as an osmolyte specifically to
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Table 6. Contents of major osmolytes in renal inner medullas of rats, treated in four groups for 42 days
Group N
Renal medullaiy osmolyte content
mmollkg wet wt SD mmolikg protein sD
Sodium Galactose Urea Galactitol Sorbitol Inositol Betaine GPC
Control 42 days 5 169 9 ND 202 69 ND 50.0 17.0 223 20 87.8 13.5 254 62
Sorbinil 42 days 5 177 10 ND 245 67 ND 21.6 9,4a 272 32 116 25 314 44
Galactose 42 days
Sorbinil + galactose 42 days
5
5
174 18138 12 24.7 9.8a5.0 30ab 215 36159 51k' 216 5950.8 l1.1' 23.2 3,4a3•3 1ab 192 23188 25 117 1783.6 122b 228 37182 17
Significance (P)'
Sorbinil 0.023 <0.001 NS <0.001 <0.001 0.07 NS NS
Galactose 0,024 <0.001 NS <0.001 <0.001 <0.001 NS <0.001
Interaction 0.005 0.001 0.05 <0.001 NS 0.03 0.003 0.008
N indicates number of animals; ND, not detected.
a Significantly different from Control group (P < 0.05, SNK multiple comparison tests)
b Significantly different from Galactose group (P < 0.05, SNK multiple comparison tests)C Two-way analysis of variance; NS, not significant (P> 0.05)
offset excessive intracellular poiyols [16]. But from our data, renal
galactitol accumulation does not appear to cause intracellular
osmolytes to be excessive (Fig. 3, middle), thus reduced inositol
may in fact be non-adaptive in terms of volume regulation.
Finally, the increase in betaine contents in galactose feeding
(Fig. 2B) is more consistent with cells adapting to shrinkage; it
does not seem particularly adaptive to downregulate 3 osmolytes
and up-regulate one (betaine) simply for cell volume mainte-
nance. Thus we conclude that galactitol accumulation does not
cause cell swelling, but that it and galactose diuresis lead to
depletion of other osmolytes, with betaine then up-regulated to
compensate.
Responses to polyol reduction
In all sorbinil-fed animals, renal betaine contents generally
increased (Tables 4 to 6, ANOVA values; Figs. 2A, C). Previously
we found the same trend for 10- and 71-day sorbinil treatments of
normal Wistar rats [18, 19]. Renal betaine content also rose 85%
in sorbinil-galactose-fed Sprague-Dawley rats [16], and also rose
in our galactose treatment (Fig. 2B) as discussed above. Betaine
has been seen to increase in renal medullas when urea, GPC and
inositol contents were reduced by salt loading or low-protein diets
[29, 30]. Thus renal cells may be programmed to use betaine as a
substitute osmolyte for volume regulation when other osmolytes
are reduced. As a methylamine, however, betaine has different
properties (such as urea counteraction) than polyols [33], so that
this substitution may not be without problems.
The mechanism for this process is unknown. Betaine accumu-
lation is stimulated in renal cells in vitro by external hypertonicity
through a Na/Cl-dependent membrane transporter [34]. This
could be stimulated when galactose increases external osmotic
pressure and/or when other cell osmolytes are suppressed. In our
42-day Sorbinil + Galactose group, betaine did not rise despite
reduced sorbitol and GPC (Fig. 2C). However, since renal Na
and galactose contents fell (Table 6; Fig. 3), betaine would not be
needed for cell volume maintenance, again suggesting that it is
used as a compensatory osmolyte specifically in response to cell
shrinkage.
Betaine compensation is not universal, however. Bondy et al
[16], using female Sprague-Dawley rats fed sorbinil for 10 days,
found papillary sorbitol contents were greatly reduced, but no
other osmolyte (including betaine) changed; total osmolytes de-
creased, suggesting osniotic stress. We also saw no significant
changes in other osmolytes in our 21 day results (Fig. 2A).
However, the increase in average betaine, though not significant
by itself (Table 5; Fig. 2A), replaced the lost sorbitol exactly,
keeping total organic osmolytes constant (Fig. 3, left).
Time-dependent patterns
Finally, there are some patterns that relate to animal age or
length of experimental treatment. First, effects of galactose feed-
ing changed with time. After 10 days, galactosemia appears to
dehydrate the kidney as indicated by elevated Na (Table 4 and
Fig. 3) and protein contents (Table 1A), but sorbitol, inositol and
GPC contents decreased in the presence of galactitol such that
osmolyte total appeared deficient (Fig. 3 middle). This could
suggest cell shrinkage, surprising given that excessive polyol
build-up is generally thought to cause cell swelling. However, the
kidney appears to adapt later to this, with Na contents lower and
total cell osmolytes higher at 21 and 42 days than at 10 days (Fig.
3 middle).
Lenticular galactose and galactitol accumulation was much
reduced at 42 days compared to 10 days (Table 3). Repeated
increases and decreases with time of galactose feeding have been
reported in rat lenses, but the reasons are unclear [35].
Second, in sorbinil feeding alone for 42 days, inositol and GPC
also increased with betaine (Table 6 and Fig. 2A; the apparently
higher total of cell osmolytes was not significantly so; Fig. 3). We
only found increased betaine in 71 days sorbinil feeding [19],
suggesting the 42 day pattern is a temporary effect. Sorbinil-only
feeding tended to cause higher urea levels in urine, plasma and
kidneys (Tables 1, 2, 5, 6), with the 42 day group having the
highest levels; this may have triggered the increased GPC (see
above). This effect of sorbinil suggests increased protein catabo-
lism, but we can find no reports of similar effects in the literature,
and have no explanation for it.
Third, in sorbinil-galactose feeding, by 42 days there were
reduced Na and galactose contents in kidneys and Na in urine
(Tables 1C, 6; Fig. 3 right), suggesting a reduced glomerular
filtration rate (GFR). Total cell osmolytes decreased in apparent
compensation (Fig. 3). Bank et a! [10] found that, while galactose
feeding increased GFR in rats, 10 to 14 days sorbinil + galactose
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feeding (but not sorbinil alone) reduced it below that of controls.
The mechanism for this was not determined, but a stimulation of
vascular smooth muscle by sorbinil was suggested [10].
Finally, there may developmental changes in AR-type activities.
Animals at 21 days of testing were chronologically about 73 days
old, about at the age of sexual maturation. Compared to younger
or older animals (10 day and 42 day groups), they had higher AR
activities as measured by glyceraldehyde (Fig. 1), more galactitol
accumulation (Fig. 2B; Tables 4 to 6), and less of a reduction in
polyols under sorbinil treatments (Figs. 2A, C). Because xylose-
based activity did not differ among groups (Fig. 1), some of the
apparent AR activity at 21 days may be attributable to aldehyde
reductase (A1R) (Results), or perhaps to a separate "high Kin"
aldose reductase recently reported in dog renal medulla [36]. Both
enzymes can use galactose as a substrate (though not nearly as
well as does aldose reductase), and both are less sensitive to
sorbinil [36, 37]. This might explain the greater resistance to
sorbinil in our 21 day animals, analogous to previous work [37]
showing that AR-specific inhibitors reduce polyols in the renal
medulla (where AR dominates) more so than in the cortex (where
both AR and AiR occur). This might also explain our previous
results with rats on sorbinil for 21 days (chronologically about 77
days old) which showed no drop in renal sorbitol contents [19].
Other studies have shown age-related changes in AR. Newborn
Sprague-Dawley rats have been have little AR mRNA, but
develop high levels by 12 days [38]. AR activity may continue to
fall after maturation: in our previous study of rats on sorbinil for
71 days (final age 125 days), medullary AR activities with glycer-
aldehyde were 34.1 4.5 units in control, 9.4 1.5 units in
sorbinil animals [19] (compare values to Fig. 1). Thus there may
be lifelong developmental changes in polyol metabolism, with
animal age possibly important to the effectiveness of aldose
reductase inhibitors.
In conclusion, the mammalian renal inner medulla generally
appears to be able to alter its total contents of organic osmolytes
when subjected to disturbances by galactosemia and aldose reduc-
tase treatment. However, the patterns of osmolyte changes are not
the same at all animal ages or lengths of treatment.
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